ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0513

Spirulina Activates IFNγ via TLR4 in Dermatomyositis Skin and Peripheral Blood

DeAnna Diaz1, Thomas Vazquez2, Christina Bax3, Jay Patel4, Madison Grinnell5, Emily Keyes6, Yubin Li5 and Victoria Werth7, 1Philadelphia College of Medicine, Philadelphia, PA, 2FIU Wertheim College of Medicine, Virginia Beach, VA, 3Corporal Michael J. Crescenz VAMC/ Department of Dermatology, U Penn, Philadelphia, PA, 4Corporal Michael J. Crescenz VAMC, Department of Dermatology, U Penn, Philadelphia, NJ, 5Corporal Michael J. Crescenz VAMC, Department of Dermatology, U Penn, Philadelphia, PA, 6Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania and Philadelphia VAMC, Philadelphia, PA, 7University of Pennsylvania, Philadelphia, PA

Meeting: ACR Convergence 2021

Keywords: Dendritic cells, Dermatology, dermatomyositis, Monocytes/macrophages, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Cytokines & Cell Trafficking Poster (0508–0516)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Our group has previously shown that Spirulina, a popular herbal supplement with purported immune boosting effects, is temporally associated with dermatomyositis (DM) onset and flare. We have previously shown in vitro that Spirulina induces IFNγ.

Methods: Here, we sought to identify which cells and inflammatory pathways are activated as a result of Spirulina stimulation in DM patients. Given the important differences between the blood and end organ immune compartments, we sought to interrogate the effects of Spirulina in both blood and skin. We utilized multiplexed flow cytometry on DM patient PBMCs stimulated with 0.3mg/mL of Spirulina. Using GraphPad prism V8.4.3, comparisons between healthy controls and DM were made with Students t-test and comparison of multiple groups were made by one way ANOVA with a post hoc Tukey test. Correlations were analyzed with Pearson’s r. With flow cytometry, we investigated Spirulina’s immunostimulatory effects at the cellular level. Eight cell lineages were evaluated in PBMCs using FACS Symphony A3 Lite and analyzed with FlowJo V10.7.1.

Results: When evaluating % change in activation with 0.3 mg/ml of Spirulina in DM and HC for IFNγ, monocyte-derived DCs (moDCs) and classical monocytes (CMs) had a significantly greater % increase in CMs and moDCs in DM compared to HC (Figure 1). With stimulation at 0.3 mg/mL of Spirulina, the IFNγ+ moDCs MFI increased by 11.7 fold relative to no stimulation (p< 0.0001). The MFI of CMs secreting IFNγ increased 32.0 fold with 0.3 mg/mL when compared to no added Spirulina (p< 0.0001) (Figure 2a and 2b). Pre-treatment with TLR4 inhibitor prior to Spirulina 0.3mg/ml of stimulation suppressed the MFI of IFNγ activation by 63.07% in moDCs, and by 73.4% in CMs (p< 0.05 and p< 0.001, respectively). We then performed imaging mass cytometry on lesional DM skin from patients with new-onset DM and a clear history of novel Spirulina consumption in the immediately preceding period (Spir-DM). Unsupervised clustering of dermal cells using the Phenograph algorithm yielded 14 unique cell types. MoDCs were manually gated on CD14 and CD11c. CMs, were the predominant cell type (16.1%), followed by CD4 T cells (14.6%), CD163+ macrophages (9.6%), and moDCs (9.3%). There was overlap of CD14, CD11c, and IFNγ in Spir-DM skin, supporting an important role for moDCs and CM in the production of IFNγ. We then compared IFNγ and TLR4 expression in DM (Figure 3a) and Spir-DM (Figure 3b), finding a stronger positive correlation in Spir-DM (r=0.97) than in DM alone (r=0.73).

Conclusion: These results further implicate Spirulina as a likely culprit in the development of DM in some patients. Our data suggest that Spirulina may promote autoimmunity via production of IFNγ in CMs and moDCs in both the blood and skin, thereby implicating Spirulina in the development of DM in some susceptible patients.

Cell specific production of IFNγ as a percent change of parent population with 0.3 mg/ml of Spirulina in dermatomyositis and healthy control patients measured by multiplexed flow cytometry.

IFNγ production is stimulated by 0.3mg/mL of Spirulina in moDCs and CMs and is suppressed by inhibition of TLR4.

TLR4 expression is positively correlated with IFNγ production in DM (r=0.73) and Spir-DM (r=0.97) skin.


Disclosures: D. Diaz, None; T. Vazquez, None; C. Bax, None; J. Patel, None; M. Grinnell, None; E. Keyes, None; Y. Li, None; V. Werth, None.

To cite this abstract in AMA style:

Diaz D, Vazquez T, Bax C, Patel J, Grinnell M, Keyes E, Li Y, Werth V. Spirulina Activates IFNγ via TLR4 in Dermatomyositis Skin and Peripheral Blood [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/spirulina-activates-ifn%ce%b3-via-tlr4-in-dermatomyositis-skin-and-peripheral-blood/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spirulina-activates-ifn%ce%b3-via-tlr4-in-dermatomyositis-skin-and-peripheral-blood/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology